Eli Lilly and

NYSE: LLY · Real-Time Price · USD
737.72
15.15 (2.10%)
At close: May 30, 2025, 3:59 PM
739.00
0.17%
After-hours: May 30, 2025, 05:56 PM EDT

Eli Lilly and Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Collaboration and Other Revenue Revenue 4.29B 5.31B 3.08B 2.36B 1.84B 1.94B
Collaboration and Other Revenue Revenue Growth -19.12% +72.49% +30.42% +27.94% -5.00% n/a
Product Revenue 40.75B 28.81B 25.46B 25.96B 22.69B 20.38B
Product Revenue Growth +41.42% +13.16% -1.91% +14.38% +11.37% n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013 Dec 31, 2012
China Revenue 1.66B 1.54B 1.45B 1.66B 1.12B 3.77B 4.23B 3.94B 3.77B 3.94B 4.51B 4.34B 4.26B
China Revenue Growth +7.84% +5.98% -12.56% +48.75% -70.33% -11.02% +7.30% +4.65% -4.45% -12.49% +3.88% +1.85% n/a
Europe Revenue 6.92B 6.17B 4.3B 4.78B 4.19B 2.55B 2.49B 2.42B 2.33B 2.03B 2.03B n/a n/a
Europe Revenue Growth +12.08% +43.62% -10.00% +14.07% +64.38% +2.16% +3.06% +3.81% +14.65% +0.30% n/a n/a n/a
Japan Revenue 1.81B 1.67B 1.75B 2.37B 2.58B 12.72B n/a 12.79B 11.51B 10.1B 9.13B n/a n/a
Japan Revenue Growth +8.51% -4.28% -26.18% -8.37% -79.70% n/a n/a +11.11% +13.95% +10.55% n/a n/a n/a
United States Revenue 30.38B 21.79B 18.19B 16.81B 14.23B n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth +39.39% +19.80% +8.20% +18.14% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 2.36B 2.42B 2.1B 2B 1.84B 1.92B 1.8B 1.93B 1.75B 1.55B 1.61B 1.63B 1.56B 1.52B 1.58B 1.69B 1.58B 1.55B 1.57B 1.45B 1.55B 1.7B 1.41B 1.59B 1.52B 1.79B 1.62B 1.65B 1.5B 2.29B 1.56B 1.71B 1.54B 1.79B 1.57B 1.62B 1.47B 1.8B 1.58B 1.64B 1.52B
Selling, General, and Administrative Revenue Growth -2.57% +15.46% +4.84% +9.08% -4.60% +6.69% -6.31% +10.07% +12.83% -3.96% -0.67% +4.31% +2.53% -3.71% -6.39% +6.96% +1.42% -0.97% +8.32% -6.52% -8.75% +20.24% -10.97% +4.56% -15.42% +10.95% -2.24% +10.25% -34.62% +47.49% -8.90% +10.53% -13.71% +14.35% -3.53% +10.09% -18.04% +14.13% -3.65% +7.34% n/a
Research and Development Revenue 2.73B 3.02B 2.73B 2.71B 2.52B 2.56B 2.41B 2.36B 1.99B 2B 1.8B 1.78B 1.61B 1.96B 1.71B 1.67B 1.68B 1.84B 1.47B 1.39B 1.39B 1.58B 1.38B 1.4B 1.23B 1.45B 1.34B 1.33B 1.18B 1.47B 1.32B 1.25B 1.24B 1.45B 1.24B 1.34B 1.22B 1.44B 1.14B 1.17B 1.04B
Research and Development Revenue Growth -9.56% +10.55% +0.84% +7.47% -1.56% +6.38% +2.23% +18.71% -0.54% +10.70% +1.18% +10.67% -17.83% +14.66% +2.16% -0.71% -8.34% +25.43% +5.41% -0.14% -11.97% +14.52% -1.52% +13.95% -15.36% +8.23% +0.77% +13.27% -20.11% +11.66% +5.48% +1.02% -14.64% +17.32% -7.45% +9.41% -15.45% +26.31% -2.23% +12.53% n/a